SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Glynn Tricia

(Last) (First) (Middle)
PRUDENTIAL TOWER, 800 BOYLSTON STREET,
SUITE 3300

(Street)
BOSTON MA 02199-8069

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
First Watch Restaurant Group, Inc. [ FWRG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/03/2023
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Rule 10b5-1(c) Transaction Indication

  
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/03/2023 S(1) 450,000(2) D $16.424(1) 34,089,784(3) I See Notes(3)(4)(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. See Exhibit 99.1 for text of footnote (1).
2. See Exhibit 99.1 for text of footnote (2).
3. See Exhibit 99.1 for text of footnote (3).
4. See Exhibit 99.1 for text of footnote (4).
5. See Exhibit 99.1 for text of footnote (5).
Remarks:
Exhibit 99.1 (Footnotes to Form 4) is incorporated by reference.
/s/ Tricia Glynn 07/06/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 99.1
Footnotes to Form 4
(1)
The shares of common stock were sold pursuant to the underwriters’ exercise of their over-allotment option in connection with a public offering of the common stock of the Issuer pursuant to the prospectus dated November 7, 2022, and accompanying registration statement on Form S-3 (File No. 333-268197). The shares were sold at a price per share equal to the public offering price.

(2)
Represents shares of common stock sold by the following entities: (i) 26,969 shares of common stock sold by Advent International GPE VIII Limited Partnership; (ii) 29,273 shares of common stock sold by Advent International GPE VIII-B-1 Limited Partnership; (iii) 21,826 shares of common stock sold by Advent International GPE VIII-B-2 Limited Partnership; (iv) 34,082 shares of common stock sold by Advent International GPE VIII-B-3 Limited Partnership; (v) 82,258 shares of common stock sold by Advent International GPE VIII-B Limited Partnership; (vi) 13,436 shares of common stock sold by Advent International GPE VIII-C Limited Partnership; (vii) 11,491 shares of common stock sold by Advent International GPE VIII-D Limited Partnership; (viii) 3,405 shares of common stock sold by Advent International GPE VIII-F Limited Partnership; (ix) 30,168 shares of common stock sold by Advent International GPE VIII-H Limited Partnership; (x) 28,052 shares of common stock sold by Advent International GPE VIII-I Limited Partnership; (xi) 27,567 shares of common stock sold by Advent International GPE VIII-J Limited Partnership (the funds set forth in the foregoing clauses (i)-(xi), the “Advent VIII Luxembourg Funds”); (xii) 63,261 shares of common stock sold by Advent International GPE VIII-A Limited Partnership; (xiii) 12,797 shares of common stock sold by Advent International GPE VIII-E Limited Partnership; (xiv) 21,704 shares of common stock sold by Advent International GPE VIII-G Limited Partnership; (xv) 12,935 shares of common stock sold by Advent International GPE VIII-K Limited Partnership; (xvi) 11,755 shares of common stock sold by Advent International GPE VIII-L Limited Partnership (the funds set forth in the foregoing clauses (xii)-(xvi), the “Advent VIII Cayman Funds”); (xvii) 995 shares of common stock sold by Advent Partners GPE VIII Limited Partnership; (xviii) 6,204 shares of common stock sold by Advent Partners GPE VIII Cayman Limited Partnership; (xix) 1,196 shares of common stock sold by Advent Partners GPE VIII-A Limited Partnership; (xx) 828 shares of common stock sold by Advent Partners GPE VIII-A Cayman Limited Partnership; and (xxi) 9,798 shares of common stock sold by Advent Partners GPE VIII-B Cayman Limited Partnership (the funds set forth in the foregoing clauses (xvii)-(xxi), the “Advent VIII Partners Funds” and together with the Advent VIII Luxembourg Funds and the Advent VIII Cayman Funds, the “Advent VIII Funds”).

(3)
Following the reported transactions, Advent International, L.P. (f/k/a Advent International Corporation, “Advent”) manages funds that collectively own 34,089,784 shares of common stock of the Issuer, which are represented as follows: (i) 2,043,069 shares of common stock held by Advent International GPE VIII Limited Partnership; (ii) 2,217,574 shares of common stock held by Advent International GPE VIII-B-1 Limited Partnership; (iii) 1,653,457 shares of common stock held by Advent International GPE VIII-B-2 Limited Partnership; (iv) 2,581,893 shares of common stock held by Advent International GPE VIII-B-3 Limited Partnership; (v) 6,231,541 shares of common stock held by Advent International GPE VIII-B Limited Partnership; (vi) 1,017,819 shares of common stock held by Advent International GPE VIII-C Limited Partnership; (vii) 870,483 shares of common stock held by Advent International GPE VIII-D Limited Partnership; (viii) 257,957 shares of common stock held by Advent International GPE VIII-F Limited Partnership; (ix) 2,285,344 shares of common stock held by Advent International GPE VIII-H Limited Partnership; (x) 2,125,090 shares of common stock held by Advent International GPE VIII-I Limited Partnership; (xi) 2,088,341 shares of common stock held by Advent International GPE VIII-J Limited Partnership; (xii) 4,792,307 shares of common stock held by Advent International GPE VIII-A Limited Partnership; (xiii) 969,411 shares of common stock held by Advent International GPE VIII-E Limited Partnership; (xiv) 1,644,184 shares of common stock held by Advent International GPE VIII-G Limited Partnership; (xv) 979,876 shares of common stock held by Advent International GPE VIII-K Limited Partnership; (xvi) 890,528 shares of common stock held by Advent International GPE VIII-L Limited Partnership; (xvii) 75,408 shares of common stock held by Advent Partners GPE VIII Limited Partnership; (xviii) 469,961 shares of common stock held by Advent Partners GPE VIII Cayman Limited Partnership; (xix) 90,612 shares of common stock held by Advent Partners GPE VIII-A Limited Partnership; (xx) 62,691 shares of common stock held by Advent Partners GPE VIII-A Cayman Limited Partnership; and (xxi) 742,238 shares of common stock held by Advent Partners GPE VIII-B Cayman Limited Partnership.

(4)
GPE VIII GP S.à.r.l. is the general partner of the Advent VIII Luxembourg Funds. GPE VIII GP Limited Partnership is the general partner of the Advent VIII Cayman Funds. AP GPE VIII GP Limited Partnership is the general partner of the Advent VIII Partners Funds. Advent International GPE VIII, LLC is the manager of GPE VIII GP S.à.r.l. and the general partner of each of GPE VIII GP Limited Partnership and AP GPE VIII GP Limited Partnership. Advent is the manager of Advent International GPE VIII, LLC, and Advent International GP, LLC is the general partner of Advent,  and may each be deemed to have voting and dispositive power over the shares held by the Advent VIII Funds.

(5)
The Reporting Person is a Managing Director of Advent and may have limited partner or other interests in one or more of the entities described herein. The Reporting Person disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or any other purpose.